LINC01619

Across TCGA pan-cancer cohorts, LINC01619 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01619 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01619 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01619 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

HNSC, OV, and CESC are the cancer types where LINC01619 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	All	0.781	0.628	<.001	90	view →
OV	OS	Median	II,III,IV	0.379	0.282	.001	62	view →
CESC	OS	Tertile	All	0.886	0.721	.001	48	view →
STAD	OS	Quartile	III,IV	0.569	0.195	.003	47	view →
KICH	OS	Median	II,III,IV	0.558	1.000	.001	42	view →
SKCM	OS	Median	All	0.411	0.267	<.001	41	view →
BRCA	DFS	Tertile	All	0.921	0.867	.003	39	view →
KIRP	DFS	Tertile	III,IV	0.097	0.940	.004	37	view →
PAAD	OS	Tertile	All	0.523	0.322	.004	33	view →
KIRC	DFS	Quartile	All	0.375	0.771	<.001	31	view →
READ	DFS	Median	All	0.617	0.775	.024	18	view →
LIHC	OS	Median	II,III,IV	0.564	0.798	.001	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01619–HNSC (DFS)

Open the HNSC breakdown →